NUCLEAR CONTROL OF CELL GROWTH AND DIFFERENTIATION PROGRAM ABSTRACT The Nuclear Control of Cell Growth and Differentiation (NC) Program is a basic science program that provides innovative approaches that lead to impactful understanding of the mechanistic basis of cancer development. The leadership, membership, and activities combine to achieve a particular aspect of the Huntsman Cancer Institute (HCI) mission statement??to understand cancer from its beginnings.? This is accomplished through experimentation focused on mechanisms underlying basic nuclear processes and pathways that go awry in cancer cells and contribute to oncogenesis. NC members use innovative discovery science and preclinical models for the purpose of dissecting fundamental aspects of cell growth and differentiation that occur in and/or impact the nucleus. Within these broad goals, research in the NC Program pursues three Specific Aims: 1) to decipher the roles of gene dysregulation in cancer; 2) to define relationships between metabolic dysregulation and gene networks in cancer; and 3) to reveal altered mechanisms of DNA damage, replication, and repair in cancer. Each of these three Specific Aims involves the investigation of both normal nuclear processes, as well as their dysregulation in cancer. A deep and fundamental understanding of both states is needed to develop the most effective diagnostics, the best tailored therapies, and the clearest and most effective guidelines related to prevention?in alignment with the mission of HCI. The NC Program has 33 members with academic appointments in 12 University of Utah departments in three schools/colleges. Program members are well funded, with a strongly positive funding trajectory that is increasingly cancer-focused. Peer-reviewed funding totals $11.1M in direct costs, of which $3.9M (35%) derives from the National Cancer Institute. Program members published 329 peer-reviewed papers; 12% represented intra-programmatic efforts and 27% resulted from inter-programmatic collaborations. Twenty- seven percent of publications were in journals with an impact factor greater than 10. As a cancer-focused basic science program, the NC Program has a major positive impact on the Cancer Center through innovation and research excellence in gene regulation, cancer metabolism, and genome stability?as well as enhancing education and training of HCI trainees in these areas. Thus, NC provides discovery science that can be translated to the clinic and population, with special attention to understanding basic mechanisms underlying cancers of high incidence in HCI?s catchment area, including melanoma, lung, breast, and childhood cancers. NC Program members continue to play leading roles in cancer-focused discovery research and partner with colleagues in all four HCI Research Programs for translational impact.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935885
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Fuller, Andrew K; Bice, Benjamin D; Venancio, Ashlee R et al. (2018) A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model. J Vis Exp :
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Faham, Najme; Zhao, Ling; Welm, Alana L (2018) mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. NPJ Breast Cancer 4:36
Rengifo-Cam, William; Shepherd, Hailey M; Jasperson, Kory W et al. (2018) Colon Pathology Characteristics in Li-Fraumeni Syndrome. Clin Gastroenterol Hepatol 16:140-141
Solomon, Benjamin L; Garrido-Laguna, Ignacio (2018) Upper gastrointestinal malignancies in 2017: current perspectives and future approaches. Future Oncol 14:947-962
Gaffney, David K; Hashibe, Mia; Kepka, Deanna et al. (2018) Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol 151:547-554
Gilcrease, Eddie B; Casjens, Sherwood R (2018) The genome sequence of Escherichia coli tailed phage D6 and the diversity of Enterobacteriales circular plasmid prophages. Virology 515:203-214
Park, Jihye; Blackburn, Brenna E; Rowe, Kerry et al. (2018) Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol 28:377-384
Hardy, Christopher M; Burke, Molly K; Everett, Logan J et al. (2018) Genome-Wide Analysis of Starvation-Selected Drosophila melanogaster-A Genetic Model of Obesity. Mol Biol Evol 35:50-65
Wu, Yelena P; Kohlmann, Wendy; Curtin, Karen et al. (2018) Melanoma risk assessment based on relatives' age at diagnosis. Cancer Causes Control 29:193-199

Showing the most recent 10 out of 1193 publications